MSMerve Nur Soykan

Merve Nur Soykan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Merve Nur Soykan has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development of Photo-Crosslinked Gelatin methacryloyl –Amniotic Membrane Hydrogel for Ocular Surface Applications

    by Onur Özalp, Burcugül Altuğ, Merve Nur Soykan, Zeynep Serra Özler, Musacan Yalçın, Eray Atalay

    The amniotic membrane is the innermost layer of the placenta, composed of a thick basal membrane and an avascular stromal matrix. Initially utilized as a skin graft in the early 20th century, it was later introduced to ophthalmology in 1940 when De Rotth proposed its use for ocular surface reconstruction. In this study, clinically used amniotic membrane was converted into a powder form, combined with gelatin methacryloyl (GelMA), and developed as a sustained-release eye drop formulation for ocular surface application. The amniotic membrane–GelMA formulation was prepared at final concentrations of 5% and 10% and photo-crosslinked to support structural integrity. Rheological analysis showed that the elastic component (G′) exceeded the viscous component (G″) across all crosslinking durations, with no marked variation in viscoelastic parameters within the tested range. The formulation exhibited shear-dependent viscosity reduction under increasing shear rates. In vitro cytotoxicity assessment using human limbal stromal mesenchymal stem cells revealed increased mitochondrial activity at 24 hours, with cell viability values of 180% in the 5% amniotic membrane group and 160% in the 10% group relative to control. At 48 and 72 hours, viability values decreased to below 100% while remaining within a non-cytotoxic range. Growth factor analysis demonstrated measurable release of epidermal growth factor (EGF) and transforming growth factor-beta (TGF-β), reaching 313 pg/mL and 350 pg/mL, respectively, at 48 hours in the 5% group. These findings suggest that the amniotic membrane–GelMA formulation exhibits sustained factor release and biocompatible characteristics under in vitro conditions. The system may represent a non-surgical, drop-based approach for delivering amniotic membrane–derived bioactive components to the ocular surface.


  • Open Access

    Development of a High‐Sensitivity Electrochemical Biosensor for Domoic Acid and Its Cellular Impact on Human Stem and Neuron‐Like Cells

    by Emilia Qomi Ekenel, Yucel Koc, Burcugul Altug, Merve Nur Soykan, Bahar Demir Cevizlidere, Sibel Gunes Bagis, Onur Uysal, Tugba Semerci Sevimli, Murat Sevimli, Ayla Eker Sariboyaci, et al.

    Domoic acid (DA) is an important environmental neurotoxin produced by certain types of marine algae and can accumulate in seafood such as anchovies, sardines, and mussels, which are considered healthy and widely consumed globally. One of the most important issues to consider is taking necessary measures to prevent water and marine pollution and conducting proper safety controls before consuming seafood. This study aimed to develop a high‐sensitivity electrochemical biosensor system for detecting DA in seafood, aiding marine pollution monitoring. Additionally, the cytotoxicity of DA at the highest Food & Drug Administration (FDA)‐permitted concentration and the concentrations determined in this study was examined on human cells. Gene expression related to cytotoxic response, DNA repair, and neurotoxicity was analyzed using amniotic fluid‐derived mesenchymal stem cells (hAF‐MSCs) and the human neuroblastoma cell line (SH‐SY5Y) as neuron‐like cell models. DA did not significantly affect the viability of hAF‐MSCs or SH‐SY5Y cells at 48‐h exposure but slightly reduced viability at 100 μg/mL compared to the control group. DA activated the glutamate receptor in hAF‐MSCs but not in SH‐SY5Y cells. It also reduced DNA repair capacity in hAF‐MSCs, though effects on viability and proliferation likely did not manifest within 48 h. There was no change in gene expression at 75 ng/mL of DA, which indicated the tolerable daily intake set by the FDA. The SH‐SY5Y cells exhibited resistance against DA, indicating enhanced their DNA repair to prevent themselves against apoptosis and cell death. It is also supported by the upregulation of DNA repair‐related genes and the membrane transporter gene ABCG2.

  • Open Access

    Effects of r-Klotho on MMP/TIMP Balance and TNF-α in Colon Cancer and Normal Colon Epithelial Cells

    by Onur Uysal, Tayfun Şengel, Lamiya Mahmudova, Merve Nur Soykan, Ayla Eker Sarıboyacı, Sibel Güneş Bağış

    Objective: To evaluate the effects of recombinant klotho protein (r-klotho) on human colon adenocarcinoma cells (Caco-2) and normal colon epithelial cells (CCD 841 CoN), with a focus on extracellular matrix (ECM) remodeling and inflammation-related gene expression. Materials and Methods: Caco-2 and CCD 841 CoN cells were cultured in four experimental groups: CCD 841 CoN; Caco-2; r-klotho-treated CCD 841 CoN; and r-klotho-treated Caco-2. r-klotho was administered at 0.3 μg/mL, selected from a previous dose–response study as the concentration yielding the lowest relative viability in Caco-2 cells within the tested range, for 24 and 48 hours. Expression levels of MMP-1, MMP-3, MMP-13, TIMP-1, TIMP-3, and TNF-α were analysed using quantitative real-time PCR (qRT-PCR) and evaluated by the ΔΔCt method with GAPDH as the reference gene. Results: In Caco-2 cells, r-klotho significantly reduced MMP-1 and TIMP-1 expression (p

  • The Effect of Wharton s Jelly Mesenchymal Stem Cell Application on Haematological Parameters in Cows with Subclinical Mastitis

    by Ayşegül BULUT, Merve Nur Soykan, Fatih Aladağ, Ayla Eker Sariboyaci, Durmuş HATİPOĞLU, Onur Uysal, Sibel Güneş Bağiş, Süleyman Gökhan Kara, Bahar Demi̇r Cevi̇zLi̇dEre, Burcugül Altuğ, et al.

    This study aimed to investigate the effect of intramammary Wharton's Jelly mesenchymal stem cell (WJ-MSC) administration on haematological parameters in cows with subclinical mastitis. In the study, 20 Holstein cows kept under equal care and feeding conditions during the same lactation period were used. The California Mastitis Test (CMT) was applied to identify animals with subclinical mastitis. Animals were divided into 4 groups: control (n=4, 3 ml DMEM solution, intramammary, days 2 and 9), Wharton's Jelly mesenchymal stem cells (n=4, WJ-MSCs, 2.5 x 107 WJ-MSCs, intramammary, days 2 and 9), subclinical mastitis (n=6, SM, parenteral antibiotic treatment, days 2 and 9), and SM+WJ-MSCs (n=6, 2.5 x 107 WJ-MSCs, days 2 and 9). On the 1st and 30th days of the study, blood samples were taken directly from the jugular vein under aseptic conditions into EDTA tubes containing anticoagulant for the evaluation of haematological parameters. Parameters related to infection and inflammation were evaluated in blood count analyses. It was found that the reference ranges for the parameters leukocyte (WBC), erythrocyte (RBC), haemoglobin (HGB), haematocrit (HCT), platelet (PLT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), neutrophil percentage Neu (%), and lymphocyte percentage (Lym%) varied. The WBC value, which was above the reference range on day 1, was measured within the reference range on day 30. It was found that the Neu% value, which was above the reference value in the Day 1 measurement, and the Lym% value, which was below the reference value, were within the reference values in the post-treatment measurement. The results obtained indicate that the application of WJ-MSCs has no negative effect on haematological parameters and may even play a balancing role in the inflammatory response for some parameters due to its immunomodulatory effects.

  • Therapeutic potential of human Wharton’s Jelly-derived mesenchymal stem cells (hWJ-MSCs) for treating clinical and subclinical mastitis in dairy cows

    by Durmus Hatipoglu, Mehmet Burak Ates, Ayla Eker Sariboyaci, Onur Uysal, Merve Nur Soykan, Burcugul Altug, Bahar Demir Cevizlidere, Fulya Buge Ergen, Aynaz Ghorbani, Fatih Aladag

  • Open Access

    Evaluation of Boric Acid Treatment on microRNA‐127‐5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells

    by Tuğba Semerci Sevimli, Aynaz Ghorbani, Fidan Gakhiyeva, Aliakbar Ebrahimi, Hamed Ghorbanpoor, Burcugül Altuğ, Fulya Buge Ergen, Zarifa Ahmadova, Merve Nur Soykan, Emre Tufekcioglu

    Coregulation of microRNAs (miRNAs) and cancer stem cells (CSCs) is very important in carcinogenesis. miR-127-5p is known to be downregulated in breast cancer. In this study, we aimed to investigate how boric acid (BA), known for its previously unstudied anti-cancer properties, would affect the expression of miR127-5p and genes responsible for breast cancer stem cells (BC-SCs) metastasis. BC-SCs were isolated from human breast cancer cells (MCF-7) by immunomagnetic cell separation and characterized with flow cytometry and sphere formation. The viability of BC-SCs and the determination of its IC50 value in response to boric acid (BA) were assessed via the MTT assay. Boric acid exhibited dose- and time-dependent inhibition of cell viability in cells. The IC50 doses of boric acid in MCF-7 cells and BC-SCs were 45.69 mM and 41.27 mM, respectively. The impact of BA on the expression of metastatic genes and miR127-5p was elucidated through RT-qPCR analysis. While the expression of the COL1A1 (p < 0.05) and VIM (p < 0.01) was downregulated, the expression of the miR-127-5p, ZEB1 (p < 0.01), CDH1 (p < 0.05), ITGB1 (p < 0.05), ITGA5 (p < 0.05), LAMA5 (p < 0.01), and SNAIL (p < 0.05), was up-regulated in dose-treated BC-SCs (p < 0.001) to the RT-qPCR results. Our findings suggest that boric acid could induce miR-127-5p expression. However, it cannot be said that it improves the metastasis properties of breast cancer stem cells. Graphical Abstract


  • Open Access

    Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells

    by Bahar Demir Cevizlidere, Onur Uysal, Huseyin Avci, Sibel Gunes Bagis, Tugba Semerci Sevimli, Murat Dincer, Emilia Qomi Ekenel, Suleyman Gokhan Kara, Merve Nur Soykan, Ayla Eker Sariboyaci

    Due to their high expression profile of multi‐drug resistance genes, cancer stem cells (CSCs) are the main source of drug resistance. The aim of this study was to establish a gemcitabine‐hydrochloride‐resistant (rt) human non‐small cell lung cancer (hNSCLC) cell line and their CSC line to be used as disease models in various cancer studies. In the first phase of study, a gemcitabine hydrochloride‐rt hNSCLC line cells was produced by making them rt through periodic exposure to gemcitabine hydrochloride. This acquired gemcitabine‐hydrochloride‐rt hNSCLC cell line was characterized for resistance. Subsequently, a CSC population with a CD326 + CD133 + CD44+ phenotypes was immunoselectively isolated from gemcitabine hydrochloride‐rt hNSCLCs purified from a single cell by colony forming technology. This rt CSC line was characterized for both resistance and stemness. Rt and non‐rt CSCs were analyzed and compared with each other in terms of immunophenotyping the expression profiles of ALDH1, CD90, ABCG2, CD44 and MDR1, which are CSC specific markers, of demonstrating mitotic capacity with growth curve analysis and of their ability to form tumor spheroids in three different 3D cultures. The results of this study demonstrated for the first time the successful generation of both gemcitabine‐hydrochloride‐rt hNSCLC cells and CSCs derived from gemcitabine‐hydrochloride‐rt hNSCLC cells. It was also shown that isolated and characterized rt CSCs could proliferate and form tumor spheres in vitro using three different 3D in vitro techniques. It was shown that the cell surface markers CD326, CD133 and CD44 can serve as an antibody panel for CSCs.


  • Open Access

    Crosstalk among miR ‐29, α‐SMA , and TGFβ1 /β3 in melatonin‐induced exosome ( Mel‐prExo ) treated human limbal mesenchymal stem cells ( hLMSCs ): An insight into scarless healing of the cornea

    by Burcugul Altug, Merve Nur Soykan, Sevinc Eyubova, Ayla Eker Sariboyaci, Cezmi Dogan, Onur Ozalp, Eray Atalay

    Inflammatory mediators that infiltrate the corneal stroma after corneal infections, trauma or refractive surgery can trigger the transformation of corneal keratocytes into myofibroblasts, resulting in highly irregular collagen deposition and subsequently corneal scarring. Mesenchymal stem cells (MSCs) can be used as therapeutic agents to regenerate corneal and conjunctival tissue damage, regulate inflammation, and reduce the development of limbal stem cell failure. The use of MSC‐derived exosomes as a cell‐free therapeutic vector is a novel therapeutic approach. This study aimed to assess the effect of exosomes obtained from melatonin (Mel)‐treated human limbal mesenchymal stem cells (hLMSCs) on naïve hLMSCs and to determine their influence on the antifibrotic and pro‐regenerative pathways involved in corneal scarring. hLMSCs were treated with varying concentrations of Mel, followed by isolation and characterization of the procured exosomes (Mel‐prExos). These exosomes were added to the cell culture media of naïve hLMSCs to examine their antifibrotic and pro‐regenerative effects. The expression of miR‐155, miR‐29, TGFβ1, TGFβ3, PPARγ, and α‐SMA miRNAs and genes were compared between Mel‐treated hLMSCs and Mel‐prExo‐treated hLMSCs by using real‐time PCR. We found that at 1 μM Mel and in the presence of Mel‐prExos, TGFβ1 was expressed 0.001‐fold, while TGFβ3 was expressed 0.6‐fold. miR‐29 expression was increased 38‐fold in the control‐Exo group compared to that in the control group. Changes in TGFβ1/β3 and α‐SMA expression are associated with miR‐29 and miR‐155. This approach could prove beneficial for ocular surface tissue engineering applications.


  • Open Access

    Developing a Novel Platelet‐Rich Plasma‐Laden Bioadhesive Hydrogel Contact Lens for the Treatment of Ocular Surface Chemical Injuries

    by Merve Nur Soykan, Burcugul Altug, Harun Bas, Hamed Ghorbanpoor, Huseyin Avci, Sertac Eroglu, Sultan Butun Sengel, Ayla Eker Sariboyaci, Sibel Gunes Bagis, Onur Uysal, et al.

    Permanent injury to corneal limbal stem cells after ocular surface chemical and thermal injuries is a major cause of corneal blindness. In this study, a PRP‐laden GelMA hydrogel contact lens is manufactured which is aimed to support the limbal niche after ocular surface insults thereby preventing limbal stem cell failure. GelMA with varying platelet‐rich plasma (PRP) concentrations (5%, 10%, and 20%) is photopolymerized using a visible light crosslinking system followed by characterizations of mechanical properties, growth factor release, enzymatic degradation, and in vitro cytotoxicity. The addition of 10% PRP into 10% GelMA hydrogel precursor solution results in the highest tensile and compressive modulus (38 and 110 kPa, respectively) and burst pressure (251±37.66 mmHg). Degradation time varies according to the concentration of the collagenase enzyme tested (0, 2.5, 5, and 40 µg/mL) and is most prolonged with 20% PRP. EGF and TGF‐β release profiles suggest an initial burst release followed by sustained release, most consistent in the 10% PRP sample. Although cell viability decreases on day 1, rapid recovery is observed and is approximately 120% after day 21. PRP‐laden GelMA in the form of a contact lens may be a promising biomaterial‐based treatment approach for the maintenance of limbal epithelial stem cells after ocular surface insults.


  • Comparison of exosomes secreted by synovial fluid-derived mesenchymal stem cells and adipose tissue-derived mesenchymal stem cells in culture for microRNA-127-5p expression during chondrogenesis

    by Tuğba Semerci Sevimli, Murat Sevimli, Emilia Qomi Ekenel, Burcugül Altuğ Tasa, Merve Nur Soykan, Zilif Demir Güçlüer, Ulukan İnAn, Onur Uysal, Sibel Güneş Bağış, Fatih Çemrek, et al.